14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.60 $5.47 Friday, 3rd May 2024 LGVN stock ended at $1.75. This is 3.31% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 8.67% from a day low at $1.73 to a day high of $1.88.
90 days $0.331 $5.47
52 weeks $0.331 $5.47

Historical Longeveron Inc. prices

Date Open High Low Close Volume
Mar 01, 2021 $8.15 $8.98 $7.82 $7.90 1 069 227
Feb 26, 2021 $7.39 $8.15 $7.00 $8.00 714 331
Feb 25, 2021 $7.21 $7.70 $6.86 $7.36 286 680
Feb 24, 2021 $6.46 $7.80 $6.24 $7.65 926 256
Feb 23, 2021 $6.50 $6.59 $6.02 $6.43 119 424
Feb 22, 2021 $6.50 $7.00 $6.19 $6.80 234 132
Feb 19, 2021 $7.00 $7.10 $6.01 $6.16 242 950
Feb 18, 2021 $7.20 $7.40 $6.85 $6.85 153 019
Feb 17, 2021 $7.30 $7.48 $6.55 $6.90 384 343
Feb 16, 2021 $7.70 $7.90 $7.48 $7.51 268 403
Feb 12, 2021 $10.00 $10.00 $7.25 $7.41 2 794 954
Click to get the best stock tips daily for free!

About Longeveron Inc.

Longeveron. Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, a... LGVN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT